KR101085979B1 - 항부정맥제로 사용되는 삼환계 벤조피란 화합물 - Google Patents

항부정맥제로 사용되는 삼환계 벤조피란 화합물 Download PDF

Info

Publication number
KR101085979B1
KR101085979B1 KR1020107027058A KR20107027058A KR101085979B1 KR 101085979 B1 KR101085979 B1 KR 101085979B1 KR 1020107027058 A KR1020107027058 A KR 1020107027058A KR 20107027058 A KR20107027058 A KR 20107027058A KR 101085979 B1 KR101085979 B1 KR 101085979B1
Authority
KR
South Korea
Prior art keywords
group
amino
dihydro
delete delete
pyrano
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020107027058A
Other languages
English (en)
Korean (ko)
Other versions
KR20100130249A (ko
Inventor
카쥬히코 오라이
유키히코 시게타
오사무 우에스기
타쿠미 오카다
토모유키 마츠다
Original Assignee
닛산 가가쿠 고교 가부시키 가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 닛산 가가쿠 고교 가부시키 가이샤 filed Critical 닛산 가가쿠 고교 가부시키 가이샤
Publication of KR20100130249A publication Critical patent/KR20100130249A/ko
Application granted granted Critical
Publication of KR101085979B1 publication Critical patent/KR101085979B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D515/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Dental Preparations (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020107027058A 2004-03-23 2005-03-23 항부정맥제로 사용되는 삼환계 벤조피란 화합물 Expired - Fee Related KR101085979B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2004084605 2004-03-23
JPJP-P-2004-084605 2004-03-23
PCT/JP2005/006004 WO2005090357A1 (en) 2004-03-23 2005-03-23 Tricyclic benzopyran compound as anti-arrhythmic agents

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020067021988A Division KR101019402B1 (ko) 2004-03-23 2005-03-23 항부정맥제로 사용되는 삼환계 벤조피란 화합물

Publications (2)

Publication Number Publication Date
KR20100130249A KR20100130249A (ko) 2010-12-10
KR101085979B1 true KR101085979B1 (ko) 2011-11-22

Family

ID=34962589

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020107027058A Expired - Fee Related KR101085979B1 (ko) 2004-03-23 2005-03-23 항부정맥제로 사용되는 삼환계 벤조피란 화합물
KR1020067021988A Expired - Lifetime KR101019402B1 (ko) 2004-03-23 2005-03-23 항부정맥제로 사용되는 삼환계 벤조피란 화합물

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020067021988A Expired - Lifetime KR101019402B1 (ko) 2004-03-23 2005-03-23 항부정맥제로 사용되는 삼환계 벤조피란 화합물

Country Status (30)

Country Link
US (2) US7652008B2 (https=)
EP (1) EP1732929B1 (https=)
JP (1) JP4840594B2 (https=)
KR (2) KR101085979B1 (https=)
CN (3) CN101429200B (https=)
AT (1) ATE485299T1 (https=)
AU (2) AU2005223612B2 (https=)
BR (1) BRPI0508768A (https=)
CA (1) CA2558139C (https=)
CY (1) CY1111250T1 (https=)
CZ (1) CZ2006598A3 (https=)
DE (1) DE602005024245D1 (https=)
DK (1) DK1732929T3 (https=)
EG (1) EG27163A (https=)
ES (1) ES2353021T3 (https=)
HR (1) HRP20110005T1 (https=)
IL (1) IL177950A (https=)
MX (1) MXPA06010880A (https=)
NO (1) NO339495B1 (https=)
NZ (2) NZ585606A (https=)
PL (1) PL1732929T3 (https=)
PT (1) PT1732929E (https=)
RS (1) RS51742B (https=)
RU (1) RU2380370C2 (https=)
SI (1) SI1732929T1 (https=)
SK (1) SK287994B6 (https=)
TW (1) TWI352704B (https=)
UA (1) UA91189C2 (https=)
WO (1) WO2005090357A1 (https=)
ZA (1) ZA200607388B (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101085979B1 (ko) * 2004-03-23 2011-11-22 닛산 가가쿠 고교 가부시키 가이샤 항부정맥제로 사용되는 삼환계 벤조피란 화합물
AU2007225765B2 (en) 2006-03-10 2012-05-24 Nissan Chemical Industries, Ltd. Process for producing optically active chromene oxide compound
WO2010018867A1 (ja) * 2008-08-14 2010-02-18 日産化学工業株式会社 ジ置換ベンゾピラン化合物
RU2523279C2 (ru) * 2009-04-30 2014-07-20 Ниссан Кемикал Индастриз, Лтд. Новая кристаллическая форма соединения трициклического бензопирана и способ его производства
LT2445502T (lt) 2009-06-25 2017-09-25 Alkermes Pharma Ireland Limited Heterocikliniai junginiai, skirti neurologinių ir fiziologinių susirgimų gydymui
WO2014050613A1 (ja) * 2012-09-27 2014-04-03 日産化学工業株式会社 含窒素複素環ｎ－オキシド化合物の製造方法
CN104507949B (zh) * 2012-09-27 2017-07-28 日产化学工业株式会社 高纯度的含氮杂环化合物的制造方法
EP3026047A4 (en) * 2013-07-25 2017-05-17 Nissan Chemical Industries, Ltd. Method for producing heterocyclic compound
EP3567044A4 (en) * 2017-01-06 2020-06-10 Korea University Research and Business Foundation, Sejong Campus INNOVATIVE CHINOLINONE DERIVATIVE AND PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF ALLERGIC DISEASES LIKE ASTHMA OR ATOPIA THEREFORE AS AN ACTIVE SUBSTANCE
EP3761983A1 (en) 2018-03-05 2021-01-13 Alkermes Pharma Ireland Limited Aripiprazole dosing strategy
CN108727261B (zh) * 2018-06-21 2021-09-24 济南大学 一种硝基取代喹那啶的制备方法
EP3903882B1 (en) * 2018-12-28 2025-05-21 Osaka University Therapeutic agent for inherited bradyarrhythmia
RU2754610C1 (ru) 2020-04-14 2021-09-03 Георгий Викторович ТЕЦ Препарат для лечения заболеваний, вызванных бактериями
CN115916201B (zh) * 2020-06-26 2024-09-17 国立大学法人大阪大学 药剂诱发性心动过缓及心动过缓性心律失常治疗药

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZM7682A1 (en) 1981-09-25 1983-05-23 Beecham Group Plc Active compounds
JPS5867683U (ja) 1981-10-28 1983-05-09 株式会社ナムコ 歩行ロボツト
JPH0699439B2 (ja) * 1988-02-03 1994-12-07 日産化学工業株式会社 ピラノベンゾオキサジアゾール誘導体
JP2658198B2 (ja) * 1988-06-23 1997-09-30 日産化学工業株式会社 ピラノベンゾトリアゾール誘導体
US5097037A (en) * 1989-07-17 1992-03-17 Nissan Chemical Industries, Ltd. Process for the optical resolution of pyranobenzoxadiazole compounds
JP2876712B2 (ja) * 1989-07-17 1999-03-31 日産化学工業株式会社 光学活性ピラノベンゾオキサジアゾール誘導体
US5164509A (en) * 1990-11-26 1992-11-17 E. R. Squibb & Sons, Inc. Benzodiazolo analogs
JPH07300414A (ja) * 1993-04-02 1995-11-14 Nissan Chem Ind Ltd 心不全治療薬
CZ254095A3 (en) * 1993-04-02 1996-01-17 Nissan Chemical Ind Ltd Medicaments for heart insuffiency
JP2734457B2 (ja) 1994-02-23 1998-03-30 日産化学工業株式会社 不斉エポキシ化反応
WO1995034547A1 (en) * 1994-06-10 1995-12-21 Smithkline Beecham Plc C-4 amide substituted compounds and their use as therapeutic agents
AR007115A1 (es) * 1996-05-15 1999-10-13 Hoechst Ag Cromanos sustituidos con sulfonamida, procedimiento para su preparacion, su empleo para la preparacion de medicamento o agente de diagnostico, asi como medicamento que los contiene
US6486178B1 (en) 1998-06-03 2002-11-26 Nissan Chemical Industries, Ltd. Indane derivatives
AU5444499A (en) 1998-09-01 2000-03-21 Nissan Chemical Industries Ltd. Benzoxazine derivatives
WO2000058300A1 (en) 1999-03-25 2000-10-05 Nissan Chemical Industries, Ltd. Chroman derivatives
HUP0202690A3 (en) * 1999-09-17 2005-02-28 Nissan Chemical Ind Ltd Benzopyran derivative having antiarrhytmic activity
US6555574B1 (en) 1999-09-24 2003-04-29 Nissan Chemical Industries, Ltd. 4-oxybenzopyran derivative
WO2001025224A1 (en) 1999-10-05 2001-04-12 Nissan Chemical Industries, Ltd. 4-oxybenzopyran derivative
TW589305B (en) 2001-02-14 2004-06-01 Nissan Chemical Ind Ltd 4-aminobenzopyran derivatives
HUP0400362A3 (en) 2001-06-25 2007-05-29 Nissan Chemical Ind Ltd Substituted benzopyran derivetives against arrhythmia
WO2003014113A1 (en) 2001-08-06 2003-02-20 Glenmark Pharmaceuticals Limited Novel benzopyran compounds and process for their preparation and use
KR101085979B1 (ko) * 2004-03-23 2011-11-22 닛산 가가쿠 고교 가부시키 가이샤 항부정맥제로 사용되는 삼환계 벤조피란 화합물

Also Published As

Publication number Publication date
US20080004262A1 (en) 2008-01-03
CY1111250T1 (el) 2015-06-11
AU2005223612B2 (en) 2010-06-24
CA2558139C (en) 2012-01-17
NZ549570A (en) 2010-08-27
JP2007530436A (ja) 2007-11-01
DK1732929T3 (da) 2010-12-20
RU2380370C2 (ru) 2010-01-27
CN1934116B (zh) 2012-10-10
WO2005090357A1 (en) 2005-09-29
JP4840594B2 (ja) 2011-12-21
US7652008B2 (en) 2010-01-26
CN102190661A (zh) 2011-09-21
RS51742B (sr) 2011-10-31
US7964623B2 (en) 2011-06-21
CA2558139A1 (en) 2005-09-29
AU2010202900B2 (en) 2011-10-27
CZ2006598A3 (cs) 2006-11-15
TW200600509A (en) 2006-01-01
ES2353021T3 (es) 2011-02-24
SK50792006A3 (sk) 2007-09-06
AU2005223612A1 (en) 2005-09-29
SK287994B6 (sk) 2012-09-03
EG27163A (en) 2015-08-24
IL177950A0 (en) 2006-12-31
PT1732929E (pt) 2010-12-21
KR20070009638A (ko) 2007-01-18
CN102190661B (zh) 2013-07-31
UA91189C2 (en) 2010-07-12
ZA200607388B (en) 2008-07-30
RU2006137284A (ru) 2008-04-27
HRP20110005T1 (hr) 2011-02-28
KR101019402B1 (ko) 2011-03-07
KR20100130249A (ko) 2010-12-10
NO20064819L (no) 2006-10-23
NZ585606A (en) 2011-11-25
CN1934116A (zh) 2007-03-21
MXPA06010880A (es) 2006-12-15
DE602005024245D1 (de) 2010-12-02
EP1732929B1 (en) 2010-10-20
IL177950A (en) 2013-04-30
SI1732929T1 (sl) 2010-12-31
ATE485299T1 (de) 2010-11-15
TWI352704B (en) 2011-11-21
PL1732929T3 (pl) 2011-04-29
AU2010202900A1 (en) 2010-07-29
HK1099299A1 (en) 2007-08-10
EP1732929A1 (en) 2006-12-20
BRPI0508768A (pt) 2007-02-27
CN101429200B (zh) 2012-05-30
US20100069374A1 (en) 2010-03-18
CN101429200A (zh) 2009-05-13
NO339495B1 (no) 2016-12-19

Similar Documents

Publication Publication Date Title
US7964623B2 (en) Tricyclic benzopyrane compound
EP1401823B1 (en) Substituted benzopyran derivatives against arrhythmia
KR101010676B1 (ko) 부정맥 치료에 유용한 벤조피란 화합물
JP2010065030A (ja) ３環性スピロベンゾピラン化合物
JP2010065029A (ja) 複素環ピラン化合物
HK1099299B (en) Tricyclic benzopyran compound as anti-arrhythmic agents
AU2002309284A1 (en) Substituted benzopyran derivatives against arrhythmia

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A16-div-PA0104

St.27 status event code: A-0-1-A10-A18-div-PA0104

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

Fee payment year number: 1

St.27 status event code: A-2-2-U10-U12-oth-PR1002

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

FPAY Annual fee payment

Payment date: 20141022

Year of fee payment: 4

PR1001 Payment of annual fee

Fee payment year number: 4

St.27 status event code: A-4-4-U10-U11-oth-PR1001

FPAY Annual fee payment

Payment date: 20151016

Year of fee payment: 5

PR1001 Payment of annual fee

Fee payment year number: 5

St.27 status event code: A-4-4-U10-U11-oth-PR1001

FPAY Annual fee payment

Payment date: 20161020

Year of fee payment: 6

PR1001 Payment of annual fee

Fee payment year number: 6

St.27 status event code: A-4-4-U10-U11-oth-PR1001

FPAY Annual fee payment

Payment date: 20171018

Year of fee payment: 7

PR1001 Payment of annual fee

Fee payment year number: 7

St.27 status event code: A-4-4-U10-U11-oth-PR1001

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

FPAY Annual fee payment

Payment date: 20181101

Year of fee payment: 8

PR1001 Payment of annual fee

Fee payment year number: 8

St.27 status event code: A-4-4-U10-U11-oth-PR1001

FPAY Annual fee payment

Payment date: 20191030

Year of fee payment: 9

PR1001 Payment of annual fee

Fee payment year number: 9

St.27 status event code: A-4-4-U10-U11-oth-PR1001

PR1001 Payment of annual fee

Fee payment year number: 10

St.27 status event code: A-4-4-U10-U11-oth-PR1001

PR1001 Payment of annual fee

Fee payment year number: 11

St.27 status event code: A-4-4-U10-U11-oth-PR1001

PC1903 Unpaid annual fee

Not in force date: 20221117

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

St.27 status event code: A-4-4-U10-U13-oth-PC1903

PC1903 Unpaid annual fee

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20221117

St.27 status event code: N-4-6-H10-H13-oth-PC1903